Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Prolonged pancytopenia in a gene therapy patient with ADA-deficient SCID and trisomy 8 mosaicism: a case report.

Prolonged pancytopenia in a gene therapy patient with ADA-deficient SCID and trisomy 8 mosaicism: a case report. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Prolonged pancytopenia in a gene therapy patient with ADA-deficient SCID and trisomy 8 mosaicism: a case report. Abstract Text:

    barbara c engelBarbara C Engel,greg m podsakoffGreg M Podsakoff,joanna l irelandJoanna L Ireland,e monika smogorzewskaE Monika Smogorzewska,denise a carbonaroDenise A Carbonaro,kathy wilsonKathy Wilson,ami shahAmi Shah,neena kapoorNeena Kapoor,mirna sweeneyMirna Sweeney,mark borchertMark Borchert,gay m crooksGay M Crooks,kenneth i weinbergKenneth I Weinberg,robertson parkmanRobertson Parkman,howard m rosenblattHoward M Rosenblatt,shi-qi wuShi-Qi Wu,michael s hershfieldMichael S Hershfield,fabio candottiFabio Candotti,donald b kohnDonald B Kohn,

    A patient with adenosine deaminase-deficient severe combined immune deficiency (ADA-SCID) was enrolled in a study of retroviral-mediated ADA gene transfer to bone marrow hematopoietic stem cells. After the discontinuation of ADA enzyme replacement, busulfan (75 mg/m2) was administered for bone marrow cytoreduction, followed by infusion of autologous, gene-modified CD34+ cells. The expected myelosuppression developed after busulfan but then persisted, necessitating the administration of untransduced autologous bone marrow back-up at day 40. Because of sustained pancytopenia and negligible gene marking, diagnostic bone marrow biopsy and aspirate were performed at day 88. Analyses revealed hypocellular marrow and, unexpectedly, evidence of trisomy 8 in 21.6% of cells. Trisomy 8 mosaicism (T8M) was subsequently diagnosed by retrospective analysis of a pretreatment marrow sample that might have caused the lack of hematopoietic reconstitution. The confounding effects of this preexisting marrow cytogenetic abnormality on the response to gene transfer highlights another challenge of gene therapy with the use of autologous hematopoietic stem cells.

    Prolonged pancytopenia in a gene therapy patient with ADA-deficient SCID and trisomy 8 mosaicism: a case report. Publishing Authors By Initials

    bc engelBC Engel,gm podsakoffGM Podsakoff,jl irelandJL Ireland,em smogorzewskaEM Smogorzewska,da carbonaroDA Carbonaro,k wilsonK Wilson,a shahA Shah,n kapoorN Kapoor,m sweeneyM Sweeney,m borchertM Borchert,gm crooksGM Crooks,ki weinbergKI Weinberg,r parkmanR Parkman,hm rosenblattHM Rosenblatt,sq wuSQ Wu,ms hershfieldMS Hershfield,f candottiF Candotti,db kohnDB Kohn,

    For similar pathological conditions, signs and symptoms: pathologic processes: chromosome aberrations: aneuploidy: trisomy research abstracts see: pathological conditions, signs and symptoms: pathologic processes: chromosome aberrations: aneuploidy: trisomy research

    PUBMED ID PMID:

    MEDLINE DATE:

    Prolonged pancytopenia in a gene therapy patient with ADA-deficient SCID and trisomy 8 mosaicism: a case report. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Blood

    VOLUME: 109

    Page Numbers: 503-6

    Journal Abbreviation: Blood

    ISSN: 0006-4971

    DAY: 14

    MONTH: 09

    YEAR: 2006

    Prolonged pancytopenia in a gene therapy patient with ADA-deficient SCID and trisomy 8 mosaicism: a case report. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 7603509

    Prolonged pancytopenia in a gene therapy patient with ADA-deficient SCID and trisomy 8 mosaicism: a case report. Keywords Mesh Terms:

    KEYWORDS: Trisomy

    MESH TERMS: therapy

    Chemical & Substance for Abstract: Prolonged pancytopenia in a gene therapy patient with ADA-deficient SCID and trisomy 8 mosaicism: a case report. Information

    Substance Name: Adenosine Deaminase

    Registry Number: EC 3.5.4.4

    Grant and Affiliation Information for Prolonged pancytopenia in a gene therapy patient with ADA-deficient SCID and trisomy 8 mosaicism: a case report.

    AFFILIATION: Division of Research Immunology/Bone Marrow Transplantation, General Clinical Research Center, Department of Pathology, Children's Hospital Los Angeles, CA 90027, and Baylor College of Medicine, Houston, TX, USA.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NCRR

    GRANT: M01 RR-43

    ACRONYM: RR

    MEDLINETA: Blood

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Prolonged pancytopenia in a gene therapy patient with ADA-deficient SCID and trisomy 8 mosaicism: a case report Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News